Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
CIK 1787092 · last filed 2024-09-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GBIO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
280 CONGRESS STREET
BOSTON, MA 02210
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZBIO | 10%+ Owner | 600,906 | $27.24 | $16.37M | $0 | 1 | 2024-09-18 |
| ARTV | 10%+ Owner | 194,108 | $6.16 | $1.20M | $0 | 1 | 2024-07-22 |
| BOLD | 10%+ Owner | 189,933 | $2.41 | $457.7K | $0 | 1 | 2024-04-02 |
| ACRV | 10%+ Owner | 888,130 | $1.72 | $1.53M | $0 | 1 | 2022-11-21 |
| Nuvalent, Inc. (NUVL) Delisted | 10%+ Owner | 897,671 | $123.96 | $111.28M | $0 | 1 | 2021-08-03 |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 1,343,081 | $11.13 | $14.95M | $0 | 1 | 2021-06-22 |
| EWTX | 10%+ Owner | 681,812 | $39.17 | $26.71M | $0 | 1 | 2021-03-30 |
| OLMA | 10%+ Owner | 1,273,420 | $6.62 | $8.43M | $0 | 1 | 2020-11-24 |
| ALGS | 10%+ Owner | 53,402 | $4.65 | $248.3K | $0 | 1 | 2020-10-22 |
| PMVP | 760,267 | $1.13 | $859.1K | $0 | 1 | 2020-09-29 | |
| DYN | 10%+ Owner | 1,608,785 | $15.72 | $25.29M | $0 | 1 | 2020-09-23 |
| KYMR | 10%+ Owner | 959,211 | $114.84 | $110.16M | $0 | 1 | 2020-08-27 |
| NRIX | 10%+ Owner | 784,313 | $25.55 | $20.04M | $0 | 1 | 2020-07-30 |
| Forma Therapeutics Holdings, Inc. (FMTX) Delisted | 10%+ Owner | 1,252,913 | $20.01 | $25.07M | $20.00M | 1 | 2020-06-25 |
| Generation Bio Co. (GBIO) Delisted | 10%+ Owner | 101,255 | $5.34 | $540.7K | $20.90M | 1 | 2020-06-18 |
| BDTX | 10%+ Owner | 568,185 | $1.69 | $960.2K | $0 | 1 | 2020-02-05 |
Recent Filings · Page 2 of 2
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-23 | DYN | Conv (C) | +1,608,785 | $0 | EDGAR |
| 2020-08-27 | KYMR | Conv (C) | +959,211 | $0 | EDGAR |
| 2020-07-30 | NRIX | Conv (C) | +784,313 | $0 | EDGAR |
| 2020-06-25 | Forma Therapeutics Holdings, Inc. (FMTX) Delisted | Mixed | +2,252,913 | $20.00M | EDGAR |
| 2020-06-18 | Generation Bio Co. (GBIO) Delisted | Mixed | +2,112,546 | $20.90M | EDGAR |
| 2020-02-05 | BDTX | Conv (C) | +568,185 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.